An eight-week treatment with the CRTH2 antagonist in EoE patients showed modest anti-eosinophil effects and clinical response in adult patients with active corticosteroid-dependent or corticosteroid-refractory EoE [83]. Here, PTGDR2 is linked to eosinophilic esophagitis.